619 related articles for article (PubMed ID: 31769740)
1. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
[TBL] [Abstract][Full Text] [Related]
2. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
3. Texture analysis using machine learning-based 3-T magnetic resonance imaging for predicting recurrence in breast cancer patients treated with neoadjuvant chemotherapy.
Eun NL; Kang D; Son EJ; Youk JH; Kim JA; Gweon HM
Eur Radiol; 2021 Sep; 31(9):6916-6928. PubMed ID: 33693994
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.
Partridge SC; Zhang Z; Newitt DC; Gibbs JE; Chenevert TL; Rosen MA; Bolan PJ; Marques HS; Romanoff J; Cimino L; Joe BN; Umphrey HR; Ojeda-Fournier H; Dogan B; Oh K; Abe H; Drukteinis JS; Esserman LJ; Hylton NM;
Radiology; 2018 Dec; 289(3):618-627. PubMed ID: 30179110
[TBL] [Abstract][Full Text] [Related]
5. Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.
Chamming's F; Ueno Y; Ferré R; Kao E; Jannot AS; Chong J; Omeroglu A; Mesurolle B; Reinhold C; Gallix B
Radiology; 2018 Feb; 286(2):412-420. PubMed ID: 28980886
[TBL] [Abstract][Full Text] [Related]
6. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.
Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK
Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI.
Yoshida K; Kawashima H; Kannon T; Tajima A; Ohno N; Terada K; Takamatsu A; Adachi H; Ohno M; Miyati T; Ishikawa S; Ikeda H; Gabata T
Magn Reson Imaging; 2022 Oct; 92():19-25. PubMed ID: 35636571
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models.
Suo S; Yin Y; Geng X; Zhang D; Hua J; Cheng F; Chen J; Zhuang Z; Cao M; Xu J
J Transl Med; 2021 Jun; 19(1):236. PubMed ID: 34078388
[TBL] [Abstract][Full Text] [Related]
9. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment.
Bufi E; Belli P; Di Matteo M; Terribile D; Franceschini G; Nardone L; Petrone G; Bonomo L
Eur J Radiol; 2014 Sep; 83(9):1631-8. PubMed ID: 24938669
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
11. [Texture analysis based on contrast-enhanced MRI can predict treatment response to neoadjuvant chemotherapy of breast cancer].
Sun SH; Zhou CW; Zhao LY; Zhang RZ; Ouyang H
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):344-349. PubMed ID: 28535650
[No Abstract] [Full Text] [Related]
12. Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response.
Santamaría G; Bargalló X; Fernández PL; Farrús B; Caparrós X; Velasco M
Radiology; 2017 Jun; 283(3):663-672. PubMed ID: 27875106
[TBL] [Abstract][Full Text] [Related]
13. Can unenhanced MRI of the breast replace contrast-enhanced MRI in assessing response to neoadjuvant chemotherapy?
Cavallo Marincola B; Telesca M; Zaccagna F; Riemer F; Anzidei M; Catalano C; Pediconi F
Acta Radiol; 2019 Jan; 60(1):35-44. PubMed ID: 29742918
[TBL] [Abstract][Full Text] [Related]
14. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.
Bufi E; Belli P; Costantini M; Cipriani A; Di Matteo M; Bonatesta A; Franceschini G; Terribile D; Mulé A; Nardone L; Bonomo L
Clin Breast Cancer; 2015 Oct; 15(5):370-80. PubMed ID: 25891905
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
16. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
Li W; Newitt DC; Wilmes LJ; Jones EF; Arasu V; Gibbs J; La Yun B; Li E; Partridge SC; Kornak J; ; Esserman LJ; Hylton NM
J Magn Reson Imaging; 2019 Dec; 50(6):1742-1753. PubMed ID: 31026118
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment MRI features associated with diagnostic accuracy of post-treatment MRI after neoadjuvant chemotherapy.
Eun NL; Gweon HM; Son EJ; Youk JH; Kim JA
Clin Radiol; 2018 Jul; 73(7):676.e9-676.e14. PubMed ID: 29567270
[TBL] [Abstract][Full Text] [Related]
19. Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer.
Kim Y; Kim SH; Lee HW; Song BJ; Kang BJ; Lee A; Nam Y
Magn Reson Imaging; 2018 May; 48():27-33. PubMed ID: 29278762
[TBL] [Abstract][Full Text] [Related]
20. Time Course Changes of Synthetic Relaxation Time During Neoadjuvant Chemotherapy in Breast Cancer: The Optimal Parameter for Treatment Response Evaluation.
Zhao R; Du S; Gao S; Shi J; Zhang L
J Magn Reson Imaging; 2023 Oct; 58(4):1290-1302. PubMed ID: 36621982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
